Nov. 1 at 8:55 AM
$ABEO there hasn't been any good news, but there also hasn't been bad news either. Let's paint a different picture.
What if by the end of this year Abeona will have treated 8 patients. Maybe on the Q3 2025 EC we will see revenue from 4-6 patients (12.4M - 18.6M). If I remember correctly they would not biopsy or treat any patients in November.
And by Q2 2026 they will have ramped up to 8 a month? (24.8M revenue in a month)
Compare those numbers with a 6-8 X avg biotech price/sales ratio. Or even an insanely low PE. After this November EC the bears will have little to speculate on. And with short interests this high I am expecting a massive short squeeze.
Everyone is freaking out about the stock price, while the stock market doesn't own any of us a damn thing. I will use it to my advantage. These prices are a steal. If it goes down more, I intend to buy more with a discount. More than doubled my position yesterday with fresh profits from
$KYTX . JMHO
